Indications : Medullary Thyroid Cancer(Unresectable Locally Advanced or metastatic)
Medicine Description : Caprelsa is a multi-kinase inhibitor used for medullary thyroid cancer (MTC). It blocks VEGF and RET pathways, slowing tumor growth. Taken as an oral tablet, it improves survival in advanced cases. Side effects include high blood pressure, diarrhea, skin rash, and heart rhythm disturbances. Regular ECG and blood pressure monitoring are required to manage risks.
Note: The content is from Google and open sources.
Disclaimer:
1. For prescribing information, please contact your physician.
2. Medicine will be procured based on a valid prescription only.
